almagate has been researched along with Alloxan Diabetes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Chen, W; Gao, Z; Huang, D; Huang, L; Ju, R; Kumar, A; Lee, C; Li, X; Liu, L; Mi, J; Ren, X; Tang, Z; Tian, G; Wang, B; Wang, S; Xing, L; Ye, Z; Zhang, S; Zhao, C; Zheng, L | 1 |
1 other study(ies) available for almagate and Alloxan Diabetes
| Article | Year |
|---|---|
VEGF-B inhibits hyperglycemia- and Macugen-induced retinal apoptosis.
Topics: Animals; Apoptosis; Aptamers, Nucleotide; Diabetes Mellitus, Experimental; Mice, Inbred C57BL; Rats; Retinal Diseases; Retinal Ganglion Cells; Treatment Outcome; Vascular Endothelial Growth Factor B | 2016 |